Nasrat Hakim

24 stories · following the connections

Business

Elite Pharmaceuticals and SunGen Pharma File ANDA

By Nasdaq OMXFeb 8, 2018, 4:32 PM UTC

Business

Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study

By Nasdaq OMXJan 30, 2018, 1:36 PM UTC

Business

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic

By Nasdaq OMXJan 10, 2018, 1:02 PM UTC

Business

Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP

By Nasdaq OMXJan 2, 2018, 5:56 PM UTC

Business

Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release

By Nasdaq OMXSep 20, 2017, 12:38 PM UTC

Business

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information

By Nasdaq OMXJun 14, 2017, 8:59 PM UTC

Business

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:57 PM UTC

Business

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC